Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;34(2):87-91.
doi: 10.1055/s-0037-1601854. Epub 2017 Jun 1.

Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization

Alexandra H Fairchild  1 , Sarah B White  1
Affiliations
Review

Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization

Alexandra H Fairchild et al. Semin Intervent Radiol. 2017 Jun.

Abstract

Colorectal cancer is the third most common cancer in the United States and the liver is the most common site of metastatic disease. The presence and extent of hepatic metastases are a major prognostic indicator. Although surgical resection is the accepted first-line therapy for colorectal liver metastasis, only 20 to 25% of patients are eligible for resection due to the extent and location of disease. This article discusses the current role of transarterial therapies in the treatment of colorectal liver metastases.

Keywords: DEBIRI; cTACE; colorectal liver metastases; interventional radiology; radioembolization.

PubMed Disclaimer

References

    1. Bhutiani N, Martin RC G., II Transarterial therapy for colorectal liver metastases. Surg Clin North Am. 2016;96(02):369–391. - PubMed
    1. Tsai M S, Su Y H, Ho M C et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14(02):786–794. - PubMed
    1. Bentrem D J, Dematteo R P, Blumgart L H. Surgical therapy for metastatic disease to the liver. Annu Rev Med. 2005;56:139–156. - PubMed
    1. LeGolvan M P, Resnick M. Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors. J Surg Oncol. 2010;102(08):898–908. - PubMed
    1. NCCN Guidelines Version 2. 2015 Colon Cancer, COL-7. Available at:https://www.scribd.com/document/264433721/NCCN-Colon. Accessed on April 5, 2017